Faculty and researchers pay it forward, mentoring prospective medical students through hypothesis-driven research
Center Highlights
Sakthi Sadayappan, PhD, MBA, FAHA
August 2024 – We are happy to announce that Dr. Sakthi Sadayappan, PhD, MBA, FAHA, has joined the University of Arizona College of Medicine in Tucson as the new head of the Department of Cellular and Molecular Medicine and associate director of basic science at the Sarver Heart Center, Dr. Sadayappan’s long-term research goals include discovering therapies for the treatment and prevention of genetically induced heart failure by gaining a better understanding of the role of myosin binding protein-C regulation, which controls heart muscle contraction. We are also pleased to announce that Dr. Sadayappan will be joining the University of Arizona College of Medicine – Phoenix Translational Cardiovascular Research team, where he has numerous colleagues with whom he has collaborated over the years. The director of the TCRC, Dr. Chris Glembotski, stated, “We are fortunate to have Dr. Sadayappan join U of A, as his energy, creativity, and research accomplishments will be key elements in advancing our cardiovascular research focus at the University of Arizona.” To learn more about Dr. Sadayappan, visit this web site.
Inna Gladysheva, PhD
August 2024 - Congratulations to Dr. Inna Gladysheva, PhD,Professor, Internal Medicine,who has been recently awarded an R01 grant from the National Institutes of Health (NIH) to investigate the newly discovered role of coagulation Factor XII as a stimulator of cardiac dysfunction and overt heart failure. The long-term project goal is to translate knowledge into novel therapeutic strategies needed to prevent or treat the progression of heart failure, improving its outcomes and the duration of patients’ lives.
June 2024 - We are delighted to share that Liya Yin, MD, PhD, will join the University of Arizona College of Medicine – Phoenix as a professor of internal medicine and member of the UA COMP Translational Cardiovascular Research Center. Dr. Yin’s research interests include lipid metabolism, endothelial dysfunction in diabetes, regulation of coronary circulation, coronary collateral growth, cardiovascular regeneration, heart failure and diabetic cardiomyopathy. She is a fellow of the American Heart Association (AHA) and the American Physiological Society – Cardiovascular Section.
Liya Yin, MD, PhD
Dr. Yin’s reputation as a strong advocate for scientific collaboration and discovery precedes her. Her research has been funded by the AHA and the National Institutes of Health (NIH). She has published more than 69 peer-reviewed articles and serves as a member of the AHA peer-review committees and an ad hoc member of NIH study sections. Dr. Yin is passionate about education and mentoring undergraduate, graduate, and medical students. She also serves on the committees of the American Physiological Society, the International Heart Research Society and the Council of Microcirculation Society. Please join us in welcoming Dr. Yin to the University of Arizona College of Medicine – Phoenix and to the Translational Cardiovascular Research Center.
Yanqiao Zhang, MD, FAHA
June 2024 - We are pleased to announce that Yanqiao Zhang, MD, FAHA, will join the University of Arizona College of Medicine – Phoenix and has been named director of the Diabetes, Obesity and Metabolism Program, member of the UA COMP Translational Cardiovascular Research Center and professor in the Department of Internal Medicine. Dr. Zhang is a distinguished research scientist whose work explores the pathogenesis of diseases associated with dysregulation of lipid, bile acid and glucose metabolism — including fatty liver disease, diabetes and atherosclerosis, and mechanisms underlying the pathogenesis of non-alcoholic fatty liver disease. The goal of Dr. Zhang’s research is to identify novel therapeutic approaches for treatment of these metabolic disorders. He is recognized nationally and internally for his research and the advancements his work has contributed to the body of knowledge in metabolic disorders. The importance of this research is significant as the metabolic disorders studied by Dr. Zhang affect the health and wellbeing of millions of people. Dr. Zhang has received numerous awards and honors throughout his career. Notably, he was named distinguished university professor at NEOMED in March 2024 and was recently selected as a fellow by the American Association for the Study of Liver Diseases. Dr. Zhang is currently the principal investigator on four NIH R01 grants, with three additional R01 grants in review. Please join us in welcoming Dr. Zhang to the University Arizona College of Medicine – Phoenix and to the Translational Cardiovascular Research Center.
Nipavan “Nip” Chiamvimonvat, MD
May 2024 - We are pleased to announce that Nipavan “Nip” Chiamvimonvat, MD, has been named chair of the Department of Basic Medical Sciences at the University of Arizona College of Medicine – Phoenix and Member of the UA COMP Translational Cardiovascular Research Center. Dr. Chiamvimonvat is a physician scientist whose career has been dedicated to treating patients with cardiac arrhythmia disorders. Her research focuses on understanding the cellular and molecular mechanisms contributing to cardiac arrhythmias and sudden cardiac death. Her research team was the first to identify several isoforms of small conductance Ca2+-activated K+ channels (SK channels) that underlie Ca2+-activated K+ current in human and mouse atrial myocytes, positioning SK channels as a potential novel drug target for atrial fibrillation. Her team’s research also demonstrated beneficial effects of a novel class of soluble epoxide hydrolase (sEH) inhibitors in cardiac hypertrophy, failure, and arrhythmias. Dr. Chiamvimonvat will join the U of A College of Medicine – Phoenix on July 8, 2024.
Shirin Doroudgar, PhD
May 2024 - Congratulations to Dr. Shirin Dourdgar, PhD, Assistant Professor of Medicine and Founding Member of the Translational Cardiovascular Research Center, she has been awarded a 5 year, $3.7M R01 grant from the National Institutes of Health (NIH) to investigate a novel cellular mechanism for the regulation of cardiovascular function. With this award, Dr. Doroudgar and her team will study a new mechanism that regulates how the heart secretes endocrine hormones that are required for maintaining a healthy blood pressure. The Center and College leadership congratulate Dr. Doroudgar on this impressive and important award, and we all look forward to the paradigm-shifting, highly novel, and translational research at UA COMP that will result from it.
Vlad Kalinichenko, MD, PhD
February 2024 - Congratulations to Dr. Vlad Kalinichenko, MD, PhD on being awarded $3 Million National Institutes of Health (NIH) Grant to develop new treatment methods for lung disease in premature infants. Dr. Kalinichenko said. “This new funding allows us to explore new drugs, signaling mechanisms and targeted drug delivery systems, which can be used to develop innovative approaches for treatment of serious neonatal lung diseases."
April 26, 2023 – Congratulations to TCRC member, Tobias Jakobi, PhD, who received a University of Arizona Health Sciences Career Development Award (CDA), which fosters academic careers in clinical and translational research. This award provides $75,000 in salary funding for two years, as well as $11,500/year for two years for additional research related expenses. We are especially proud of Dr. Jakobi’s achievement, as he is only the second U of A CDA awardee at the college over the nine-year tenure of this funding mechanism; the first awardee was Shirin Doroudgar, PhD, also a TCRC faculty member, who received this prestigious award last year.
Hongyu Qiu, MD, PhD
It is with great excitement that we announce the recruitment of Hongyu Qiu, MD, PhD, to the U of A College of Medicine – Phoenix Translational Cardiovascular Research Center (TCRC). Dr. Qiu is a highly successful cardiovascular researcher who has interests and expertise in both cardiac and vascular biology. Dr. Qiu has nearly 100 publications in the highest-impact journals in the field, including Circulation, Journal of Hypertension and Circulation Research. Dr. Qiu's studies focus on the cellular and molecular mechanisms of cardiovascular disease using a combination of genomic, biochemical and histological approaches in the heart, in vivo and in isolated primary cardiomyocytes — where she has studied epigenomics and proteomics by exploring the novel targets with high therapeutical potential. Dr. Qiu has been funded by the National Institutes of Health (NHLBI) continually for the last 10 years.
Won Hee Lee, PhD
We welcome Dr. Qiu to the college as a tenured professor of Medicine. She was previously a tenured professor at the Center for Molecular and Translational Medicine Institute of Biomedical Sciences at Georgia State University. Her new laboratory is on the eighth floor of the Biomedical Sciences Partnership Building on the Phoenix Bioscience Core.
January 2023 – Won Hee Lee, PhD, was nominated and selected as a recipient of the Arizona Department of Health Services, on behalf of the Arizona Biomedical Research Centre, New Investigator Award for 2023. Using a combination of human iPSC-ECs derived from healthy and T2D patients, a diabetic model and an endothelial-specific histone deacetylase 9 knockout model, this research aims to delineate novel molecular mechanisms responsible for health risks posed by e-cigs in terms of accelerating the onset and severity of obesity/diabetes.
Zhiyu Dai, PhDNovember 5-7, 2022–Zhiyu Dai, PhD, was selected as a finalist for the highly competitive and prestigious 3CPR (Cardiopulmonary, Critical Care, Perioperative and Resuscitation) Cournand and Comroe Early Career Investigator Award competition at the American Heart Association Scientific Sessions 2022 in Chicago, IL, and presented his lab's research findings.
September 29, 2022 – We celebrated the second anniversary of the Translational Cardiovascular Research Center (TCRC) at the college. We shared updates from the second year of the center’s existence — ranging from various awards and other achievements of our members to a milestone in the Center’s history, recognition as a college center by the University. We ended the celebration with a meet and greet in the Grand Canyon of the Biomedical Sciences Partnership Building and toasted to a fantastic first two years and an even better third year. A special warm thank you to Tina Allen, Bernie Sadauskas, Marci Ray and Casey Sapio who helped to make the event a great success.
September 6-9, 2022– The International Society for Heart Research (ISHR) recently awarded Erik Blackwood, PhD, the Young Investigator Competition Award (YICA) and the Litsa Kranias Early Career Investigators (ECI) Leadership Award. Dr. Blackwood received the ECI Leadership Award while presenting his research at the North American Section ISHR meeting in Winnipeg, CA.
Erik Blackwood, PhD
July 28, 2022 – We are pleased to announce that the American Heart Association’s Council on Basic Cardiovascular Sciences (BCVS), has selected Dr. Blackwood, as a finalist for the 2022 Louis N. and Arnold M. Katz Basic Science Research Prize for Early Career Investigators Competition. The finalists represent the best early career investigators of the BCVS and very few research centers ever have an investigator in this competition, making Erik’s achievement is particularly impactful for our new center. Erik will present his research as part of the competition with three other finalists at the upcoming AHA Scientific Sessions meeting in Chicago on November 5–7, 2022. We hope all TCRC members will attend the competition in-person or virtually.
Christopher Glembotski, PhD
Congratulations to Chris Glembotski, PhD, on being awarded the Department of Internal Medicine Translational Investigator of the Year, honoring him as a faculty member who demonstrates exemplary translational investigation skills and commitment to scholarship.
Congratulations to Dr. Blackwood on his multiple awards from the U of A Sarver Heart Center. Through his research, Dr. Blackwood, a researcher in the Translational Cardiovascular Research Center (TCRC), seeks to understand the molecular underpinnings of both congenital and lifestyle-driven heart failure with the goal of identifying novel therapeutic targets.
Congratulations to Alexandra “Bobbie” Garvin, PhD, a postdoctoral research fellow in the Department of Basic Medical Sciences (BMS) at the University of Arizona College of Medicine – Phoenix. She has been awarded a U of A Sarver Heart Center grant for her work entitled, “Prohibitin as a Novel Therapeutic Target for Cardiac Fibrosis.”
April 2022 – Congratulations to TCRC Member, Dr. Zhiyu Dai, who has recently been elected a Fellow of the American Heart Association (FAHA) conferred by the Council on Cardiopulmonary Critical Care, Perioperative and Resuscitation (3CPR). Fellowship recognizes and awards premium professional members for excellence, innovative and sustained contributions in the areas of scholarship, practice and/or education, and volunteer service within the AHA/ASA.
Alina Bilal, MS,theabstract has been selected for oral presentation at the ISHR World Congress in Berlin (12-15 June 2022) in the Early Career Investigator (ECI) symposium program. Only a small number of submitted abstracts are chosen for oral presentation.
April 7, 2022 – Congratulations to TCRC member and dean of the college Guy Reed, MD, MS, who was awarded a $5.5 million grant from the Flinn Foundation to establish two research faculty positions and support training to further translational research in cardiovascular diseases, neurosciences and mental health.
April 6, 2022 – Congratulations to Dr. Erik Blackwood,whose abstract has been selected for oral presentation at the ISHR World Congress in Berlin (12-15 June 2022) in the main symposium program. Only a small number of submitted abstracts are chosen for oral presentation.
March 21, 2022 – Congratulations to Aina Bilal, MS, who has been awarded an ECI Travel Award to support your attendance at the ISHR World Congress to be held in Berlin on June 12-15, 2022.
March 20, 2022 – Congratulations to Zhiyu Dai, PhD, who received an NIH RO1 on the "Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension"
March 14, 2022 – Congratulations to TCRC member, Shirin Doroudgar, PhD, who received a new University of Arizona Health Sciences Career Development Award (CDA), which fosters academic careers in clinical and translational research. This award provides 75 percent salary funding for two years to enable the focused time necessary to ensure research success. We are especially proud of Dr. Doroudgar’s achievement, as she is the first U of A CDA awardee at the college over the eight-year tenure of this funding mechanism.
February 28, 2022- Steve Goldman, MD - The National Academy of Inventors (NAI) has namedSteven Goldman, MD, professor of medicine at the University of Arizona College of Medicine – Tucson, Division of Cardiology, and the C. Leonard Pfeiffer Chair in Cardiovascular Medicine at the Sarver Heart Center to its 2022 class of Senior Members. NAI Senior Members are widely regarded as the world’s top academic inventors.
January 15, 2002 – Congratulations to TCRC members Tobias Jakobi, PhD, and Shirin Doroudgar, PhD, on being awarded BIO5 Rapid Grant titled, “Extending the circtools circular RNA software for full-length sequencing,” in the amount of $49,969.
January 15, 2022 - Congratulations to TCRC member Tobias Jakobi, PhD,and honorary TCRC member, Amelia Gallitano, MD, PhD, on being awarded a UA BIO5 Rapid Grant Award titled, “A new bioinformatic analysis to develop a diagnostic test for schizophrenia,” in the amount of $50,000.
Feb 4, 2022 – Congratulations to Dr. Blackwood, who received a 2022 Outstanding Postdoctoral Scholar Award in recognition for innovation in research, research productivity in grants and publications, and leadership, including mentoring and service nationally and internationally. The competition for this award is open to all postdoctoral fellows at the University of Arizona. Dr. Blackwood is the first-ever recipient of this award at U of A College of Medicine – Phoenix. Due to a tie, two awards were made this year; in all previous years of this competition, only one award has been made each year.
January 2022 – Congratulations to Dr. Erik Blackwood, who has been recently awarded both the Irving J. Levinson Memorial Research Award and J.G. Murray Research Award from the University of Arizona Sarver Heart Center. These awards will fund pilot studies testing the therapeutic efficacy of novel ATF6-activating compounds that Dr. Blackwood identified in large swine models of acute myocardial infarction. Dr. Blackwood will perform these large animal studies in collaboration with Dr. Steve Goldman in the hopes of establishing a pipeline for future collaborative large animal experimentation between the Phoenix and Tucson campuses. Dr. Blackwood was also recently selected as a University of Arizona Bio5 Institute Postdoctoral Fellow. In addition to being named a fellow, this award will support preliminary studies discerning a role for the unfolded protein response in heart failure with preserved ejection fraction (HFpEF) using human induced pluripotent stem cells. This award will also permit Dr. Blackwood to present his research at the 2022 International Society for Heart Research World Congress in Berlin, Germany.
January 2022 –Congratulations to Taben Hale, PhD, who was recently awarded an R01 from the NIH. This grant entitled “Targeting Resident Cardiac Fibroblast Subpopulations for Protection Against Fibrosis” will fund research on identifying targetable pathways for shifting cardiac fibroblasts towards a low activation state. The long-term goal for this work is to prevent the pathological fibrotic remodeling that underlies heart failure.
January 1, 2022 – Congratulations to Dr. Blackwoodon being awarded a UA BIO5 Postdoctoral Fellowship for his proposal, “Molecular Roles for ATF6 and the Unfolded Protein Response in Pathogenesis of Heart Failure with Preserved Ejection Fraction”. This funding will fund Dr. Blackwood’s travel to the International Society for Heart Research (ISHR) in Berlin, Germany in June of 2022, as well as research supplies necessary to perform the proposed studies.
Jonathan Lifshitz, PhDading cause of death and disability among Veterans and the general public. College of Medicine – Phoenix and Phoenix VA researchers led a collaborative group that also included scientists from Midwestern University and Barrow Neurological Institute to develop nanoliposomes (phospholipid nanoparticles) and test their efficacy in reducing stroke injury. They found that the nanoliposomes reduced the amount of brain injury by inducing an antioxidant protective response. The collaborative team was led at the College of Medicine – Phoenix and Phoenix VA by Raymond Migrino, MD,(principal investigator,Department of Internal Medicine) and Jonathan Lifshitz, PhD, (professor of Child Health and director, Translational Neurotrauma Research Program). The study is funded by VA Merit, Department of Defense, and Arizona Alzheimer’s consortium grants and will be presented at the 2021 American Heart Association meeting with simultaneous publication in Stroke journal.
Taben Hale, PhD, and Alexandra Garvin, PhD
December 2021 – Dr. Alexandra Garvin was awarded a Sarver Heart Center grant entitled “Prohibitin as a Novel Therapeutic Target for Cardiac Fibrosis” to investigate the mitochondrial protein prohibitin in the cardiac fibroblast as a novel molecular target for antifibrotic therapy during the progression to heart failure.
December 2021 -Congratulations to Dr. Erik Blackwood, who was recently elected as the chair of the Early Career Investigator Committee for the International Society for Heart Research. Dr. Blackwood will represent the University of Arizona College of Medicine – Phoenix and the entire North American Section of ISHR in this worldwide cardiovascular research community by being tasked with the planning of the World Congress in Berlin, Germany, in June 2022, as well as coordinating all activities for early career researchers globally.
December 2021 – Congratulations to Dr.Taben Hale and her collaborators Jill Goldstein, PhD, of Harvard University, and Robert Handa, PhD, from Colorado State University! They were awarded an $8 million NIH grant to study the impact of prenatal stress on the long-term risk of co-morbid depression and heart disease in offspring.
November 2021 – Frontiers in Cardiovascular Medicine — section Heart Failure and Transplantation — just launched the research topic entitled “Edema in Heart Failure with Reduced Ejection Fraction.” Inna Gladysheva, PhD and Ryan D. Sullivan, DVM, LATG, from the TCRC, along with Pierpaolo Pellicori, MD, from the University of Glasgow are serving as guest editors. The goal of this topic is to present and evaluate the mechanisms underlying edema development, which defines the transition from pre-symptomatic to symptomatic heart failure. Original research, reviews and short communications exploring existing and novel modalities for objective edema diagnostics, monitoring and treatment strategies in translational and clinical studies are encouraged for submission. The deadline for an abstract is November 30, 2021; for an invited manuscript, it is March 31, 2022.
November 1, 2021 – Congratulations to TCRC member Dr. Doroudgar on being awarded a UA Core Facilities Pilot Grant titled “Generation of a Double Transgenic Mouse Model for Cell-type—specific Inducible Endogenous Gene Activation and Repression” in the amount of $20,900.
Rod Tung, MD
June 10, 2021 – We are happy and honored to announce that Roderick Tung, MD, has been named chief of the Division of Cardiology and director of Cardiovascular Clinical Research for the Department of Internal Medicine at the University of Arizona College of Medicine – Phoenix and Banner – University Medical Center Phoenix. He will also serve as the director of the Cardiovascular Center at Banner – UMC Phoenix. Dr. Tung is an electrophysiologist and is keenly interested in translational cardiovascular research in many areas, such as ventricular tachycardia and atrial fibrillation. We welcome Dr. Tung as an inaugural member of the Translational Cardiovascular Research Center (TCRC) and look forward to many research collaborations in the future.
In April 2021, the center unveiled the cornerstone pieces of equipment in the TCRC Imaging Lab, a Leica TCS SP8 STED super-resolution confocal with white light laser, FALCON/FLIM, and Tau Sense, and a Leica DMi8 S Infinity THUNDER with TIRF module equipped with a stage top incubation chamber for live-cell imaging.
Drs. Jakobi and Doroudgar
March 2021, saw the center welcome its two newest faculty members — Drs. Tobias Jakobi and Shirin Doroudgar. Drs. Doroudgar and Jakobi come to us from one of the largest, most famous universities in Europe — the University of Heidelberg Medical School in Heidelberg, Germany. They have expertise in cell and molecular cardiology, as well as bioinformatics; and they will play key roles in overseeing the clinical stem cell lab and the precision medicine translational data management systems in the center.
Recent Publications
November 2024 - Dr. Rayna Gonzales, PhD - Publication - Trevor S Wendt, Saema Ansar, Rayna J Gonzales (2024).
April 2024 - Dr. Tanya Kalin, PhD & Dr. Vladimir V Kalinichenko, PhD - Publication - Bian F, Goda C, Wang G, Lan YW, Deng Z, Gao W, Acharya A, Reza AA, Gomez-Arroyo J, Merjaneh N, Ren X, Goveia J, Carmeliet P, Kalinichenko VV, Kalin TV. FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4. EMBO Mol Med. 2024 Apr 8. doi: 10.1038/s44321-024-00064-8. Epub ahead of print. PMID: 38589650.
October 13, 2022 - Dr. Zhiyu Dai - Publication - "TMEM100, a Lung-Specific Endothelium Gene" Arterioscler Thromb Vasc Biol (ATVB). This paper was chosen as one of only two "Featured" articles in the December 2022 issue, posting in the afternoon of 11/22.
October 10, 2022 - Dr. Steven Goldman, MD - Publication - Goldman S, Traverse JH, Zile MR, Juneman E, Greenberg B, Kelly R, Koevary JW, Lancaster JJ. "Perspective on the Development of a Bioengineered Patch to Treat Heart Failure" Vessel Plus 2022;6:54. http://dx.doi.org/10.20517/2574-1209.2021.149. See the video interview with Dr. Goldman about this publication at the following link: https://v1.oaepublish.com/images_2018/journals/vp_221026.mp4
August 3, 2022- Drs. Gladysheva, Sullivan and Reed - Publication - “Soluble (Pro)Renin Receptor Levels Are Regulated by Plasma Renin Activity and Correlated with Edema in Mice and Humans with HFrEF.” Biomedicines. 2022 Aug 3;10(8): 1874.
April 14, 2022 - Drs. Gladysheva, Sullivan and Reed - Publication - "Sodium-Glucose Cotransporter-2 Inhibitors Improve Heart Failure with Reduced Ejection Fraction Outcomes by Reducing Edema and Congestion."Diagnostics. 2022 Apr 14;12(4):989.
August 19, 2022 - Drs. Gladysheva, Sullivan and Reed - Publication - “Suppression of Cardiogenic Edema with Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction: Mechanisms and Insights from Preclinical Studies.” Biomedicines. 2022 Aug 19;10(8):2016.
July 2022 A study investigating mechanisms of severe pulmonary arterial hypertension by TCRC Member, Dr. Zhiyu Dai, and colleagues was published in the July 2022 issue of The European Respiratory Journal. Bin Liu, Yi Peng, Dan Yi, Narsa Machireddy, Daoyin Dong, Karina Ramirez, Jingbo Dai, Rebecca Vanderpool, Maggie M. Zhu, Zhiyu Dai and You-Yang Zhao, published a peer-reviewed original research article entitled "Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension," suggesting that endothelial PHD2 deficiency in progressive obliterative vascular remodeling decreases caveolin-1 expression. This leads to augmented nitrative stress, which contributes to obliterative pulmonary vascular remodeling and severe pulmonary hypertension.
April 2022 A publication by TCRC Member, Dr. Ryan Sullivan and colleagues appeared in the April 2022 issue of Circulation, Emmanuel M. Camors, Alyson H. Roth, Joseph R. Alef, Ryan D. Sullivan, Jason N. Johnson, Enkhsaikhan Purevjav, and Jeffrey A. Towbin, published a peer-reviewed original research article entitled “Progressive Reduction in Right Ventricular Contractile Function Due to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.” explored a new knock-in mouse model and its translational validity by comparing phenotypic features to ACM patient cardiac biopsies.
April 2022 issue of the American Journal of Physiology Heart and Circulatory, L. Madhavpeddi, B. Hammond, D.L. Carbone, P. Kang, R.J. Handa and T.M. Hale published a peer-reviewed research paper titled "Impact of angiotensin II receptor antagonism on the sex-selective dysregulation of cardiovascular function induced by in utero dexamethasone exposure." This paper provides research on in utero exposure to glucocorticoids in late gestation programs changes in cardiovascular function. The objective of this study was to determine the degree to which angiotensin II mediates sex-biased changes in autonomic function as well as basal and stress-responsive cardiovascular function following in utero glucocorticoid exposure.
March 2022 issue of Scientific Reports, Craig C. Morris, Jacob Ref, Satya Acharya, Kevin J. Johnson, Scott Squire, Tuschar Acharya, Tyler Dennis, Sherry Daugherty, Alice McArthur, Ikeotunye Royal Chinyere, Jen Watson Koevary, Joshua M. Hare, Jordan J. Lancaster, Steven Goldman, and Ryan Avery published a peer-reviewed research paper titled "Free-breathing gradient recalled echo-based CMR in a swine heart failure model." This paper provides research on swine models and the well-established protocols for creating a closed-chest myocardial infarction (MI), as well as protocols for characterization of cardiac function with cardiac magnetic resonance (CMR). This methods manuscript outlines a novel technique in CMR data acquisition utilizing smart-signal gradient recalled echo (GRE)-based array sequences in a free-breathing swine heart failure model allowing for both high spatial and temporal resolution imaging.
March 2022 issue of Pulmonary Circulation, Bin Liu, Dan Yi, Jiakai Pan, Jingbo Dai, Maggie M. Zhu, You-Yang Zhao, S. Paul Oh, Michael B. Fallon, and Zhiyu Dai published a peer-reviewed research paper titled "Suppression of BMP signaling by PHD2 deficiency in Pulmonary Arterial Hypertension." This paper provides their research findings on how they demonstrated that PHD2 deficiency suppresses BMP signaling in the lung endothelial cells, suggesting the novel mechanisms of dysregulated BMP signaling in the development of pulmonary arterial hypertension.
November 2021 issue of the Journal of the American Heart Association, Zhiyu Dai, Jianding Cheng, Bin Liu, Dan Yi, Anlin Feng, Ting Wang, Lingling An, Chen Gao, Yibin Wang, Maggie M. Zhu, Xianming Zhang and You-Zhao published a peer-reviewed research paper titled "Loss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis." This paper provides their research findings on how cardiac hypertrophy and fibrosis are common adaptive responses to injury and stress and how they define, for the first time, the unexpected role of endothelial PHD2 deficiency in inducing cardiac hypertrophy and fibrosis in an HIF‐2α–dependent manner.
October 2021 issue of Science Direct, Jessika Iwanski, Sobhi G. Kazmouz,Shuaizhi Li, Ben Stansfield, Tori T. Salem, Samantha Perez-Miller, Toshinobu Kazui, Lipsa Jena, Jennifer L. Uhrlaub, Scott Lick, Janko Nikolich-Žugich, John P. Konhilas, Carol C. Gregorio, May Khanna, Samuel K. Campos, andJared M. Churko published a peer-reviewed research paper titled "Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells." This paper outlines their research findings on pathogenicity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its ability to enter through the membrane-bound angiotensin-converting enzyme 2 (ACE2) receptor.
September 2021 issue of Tissue Engineering Part B: Reviews, Tori Salem, Zachary Frankman, and Jared Churko published a peer-reviewed research paper titled "Tissue engineering techniques for iPSC derived three-dimensional cardiac constructs," which shows how recent developments in applied developmental physiology have provided well-defined methodologies for producing human stem-cell derived cardiomyocytes. Cardiomyocytes produced in this way have become commonplace as cardiac physiology research models. This review provides a readable, broad-reaching and thorough discussion of major factors to consider for the development of cardiovascular tissues from stem cell derived cardiomyocytes.
July 2021 issue of Stem Cells International, Ikeotunye Royal Chinyere, Pierce Bradley, Joshua Uhlorn, Joshua Eason, Saffie Mohran, Giuliana G. Repetti,Sherry Daugherty, Jen Watson Koevary, Steven Goldman and Jordan J. Lancaster published a peer-reviewed research paper titled "Epicardially Placed Bioengineered Cardiomyocyte Xenograft in Immune-Competent Rat Model of Heart Failure." The article presents information on how human-induced pluripotent stem-cell-derived cardiomyocytes (hiPSC-CMs) are under preclinical investigation as a cell-based therapy for heart failure post-myocardial infarction. This study is aimed at confirming the graft therapeutic efficacy in an immune-competent chronic heart failure (CHF) model and providing an evaluation of the in vitro properties of the tissue graft.
May 2021 issue of the American Journal of Physiology, Kayleigh Marsh, Adrian Arrieta, Donna Thuerauf, Erik Blackwood, Lauren MacDonnell, and Chris Glembotski published a peer-reviewed research paper titled “The peroxisomal enzyme, FAR1, is induced during ER stress in an ATF6-dependent manner in cardiac myocytes.” This paper is one of the first studies of peroxisomes in cardiac myocytes and makes the link between ER stress in the heart and its effects on the function of peroxisomes.>
April 2021 issue of the International Journal of Molecular Sciences (Special Issue Heart Failure: From Molecular Basis to Therapy.2.0), Ranjana Tripathi, Ryan Sullivan, Tai-Hwang Fan, Radhika Mehta, Inna Gladysheva, and Guy Reed published a peer-review translational research paper titled “A Low-Sodium Diet Boosts Ang (1–7) Production and NO-cGMP Bioavailability to Reduce Edema and Enhance Survival in Experimental Heart Failure”. This paper reports the pathophysiological outcomes (cardiac function, pulmonary and systemic edema, blood pressure, kidney function, survival) and underlining mechanisms of a low-sodium diet on the progression of experimental normotensive dilated cardiomyopathy to symptomatic HFrEF in randomized, blinded pre-clinical trial. The beneficial molecular pathways related outcomes of the low-sodium diet included increases in ACE2, Ang (1–7), NO and cGMP, which acted to compensate for the deleterious effects of systemic classical RAAS activation observed with this diet.
